According to the Zhitong Finance App, the US and China Jiahe (02453) issued an announcement. Beijing Taihecheng Medical Technology Co., Ltd. (Beijing Taihecheng), one of the controlling shareholders of the company, used Zhongcheng Trust Co., Ltd. (Zhongcheng) as the beneficiary to pledge 35.623 million H shares as a guarantee for loan financing up to a total of not more than RMB 500 million (H share pledge). On September 8, 2026, the company was notified by Beijing Taihecheng that (i) all H share pledges had been lifted; (ii) on the same day, Beijing Taihecheng had pledged 356.023 million H shares of the company as beneficiaries, accounting for about 100% of the total shares directly held by Beijing Taihecheng in the company, as a guarantee that Zhongcheng provided the Group with a total loan financing of no more than RMB 300 million. As of the date of this announcement, the company's H shares pledged by Beijing Taihecheng accounted for about 4.54% of the company's total issued shares. As far as directors are well aware, Zhongcheng is an independent third party to the company and its related parties.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.